Both S. nigrum L. extract and the newly identified GA of this plant, solaoiacid, inhibit the FASN-EGFR signaling pathway and affect the migration, autophagy, apoptosis, and immune response of non-small cell lung cancer (NSCLC) cells. Here, FASN is linked to non-small cell lung carcinoma.